Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

Healthcare Biotechnology
"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

BioExx Specialty Proteins Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Comment by DrAuditon Mar 09, 2012 8:06pm
230 Views
Post# 19652152

RE: RE: RE: RE: RE: RE: RE: Kevin O'Leary and Stev

RE: RE: RE: RE: RE: RE: RE: Kevin O'Leary and Stev

The issue is the q4 losses and the financials. Usually they are filed. Y this time. Td announced they would be available Monday. Now we learn not. 

  

A company with no customers and no revenues does not take ten weeks to close its books   There is no receivables payables confirmation going on.  There is no credit cycle.

dialogue about delay being caused by jv discussion is wrong. The financials are as at dec 31, so current negotiations with a purchaser are irrelevant. 

 

It is easy to speculate that the dealt in reporting is due to dialogue with the new auditors a out asset impairment.  And the go forward viability of the enterprise. 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities